Pharmacovigilance Risk Assessment Committee (PRAC): 31 August - 3 September 2026, European Medicines Agency, Amsterdam, the Netherlands, from 31 August 2026 to 3 September 2026

Submitted by Anonymous (not verified) on 24 October 2024 - 14:58

Pharmacovigilance Risk Assessment Committee (PRAC): 31 August - 3 September 2026, European Medicines Agency, Amsterdam, the Netherlands, from 31 August 2026 to 3 September 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 3 - 6 August 2026, European Medicines Agency, Amsterdam, the Netherlands, from 3 August 2026 to 6 August 2026

Submitted by Anonymous (not verified) on 24 October 2024 - 14:57

Pharmacovigilance Risk Assessment Committee (PRAC): 3 - 6 August 2026, European Medicines Agency, Amsterdam, the Netherlands, from 3 August 2026 to 6 August 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 6 - 9 July 2026, European Medicines Agency, Amsterdam, the Netherlands, from 6 July 2026 to 9 July 2026

Submitted by Anonymous (not verified) on 24 October 2024 - 14:56

Pharmacovigilance Risk Assessment Committee (PRAC): 6 - 9 July 2026, European Medicines Agency, Amsterdam, the Netherlands, from 6 July 2026 to 9 July 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 8 - 11 June 2026, European Medicines Agency, Amsterdam, the Netherlands, from 8 June 2026 to 11 June 2026

Submitted by Anonymous (not verified) on 24 October 2024 - 14:54

Pharmacovigilance Risk Assessment Committee (PRAC): 8 - 11 June 2026, European Medicines Agency, Amsterdam, the Netherlands, from 8 June 2026 to 11 June 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 4 - 7 May 2026, European Medicines Agency, Amsterdam, the Netherlands, from 4 May 2026 to 7 May 2026

Submitted by Anonymous (not verified) on 24 October 2024 - 14:53

Pharmacovigilance Risk Assessment Committee (PRAC): 4 - 7 May 2026, European Medicines Agency, Amsterdam, the Netherlands, from 4 May 2026 to 7 May 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 7 - 10 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2026 to 10 April 2026

Submitted by Anonymous (not verified) on 24 October 2024 - 14:52

Pharmacovigilance Risk Assessment Committee (PRAC): 7 - 10 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2026 to 10 April 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 9 - 12 March 2026, European Medicines Agency, Amsterdam, the Netherlands, from 9 March 2026 to 12 March 2026

Submitted by Anonymous (not verified) on 24 October 2024 - 14:51

Pharmacovigilance Risk Assessment Committee (PRAC): 9 - 12 March 2026, European Medicines Agency, Amsterdam, the Netherlands, from 9 March 2026 to 12 March 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 9 - 12 February 2026, European Medicines Agency, Amsterdam, the Netherlands, from 9 February 2026 to 12 February 2026

Submitted by Anonymous (not verified) on 24 October 2024 - 14:50

Pharmacovigilance Risk Assessment Committee (PRAC): 9 - 12 February 2026, European Medicines Agency, Amsterdam, the Netherlands, from 9 February 2026 to 12 February 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 12 - 15 January 2026, European Medicines Agency, Amsterdam, the Netherlands, from 12 January 2026 to 15 January 2026

Submitted by Anonymous (not verified) on 24 October 2024 - 14:49

Pharmacovigilance Risk Assessment Committee (PRAC): 12 - 15 January 2026, European Medicines Agency, Amsterdam, the Netherlands, from 12 January 2026 to 15 January 2026

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness